Clinical Trials Directory

Trials / Completed

CompletedNCT01169740

Transcutaneous Measurement of Jaundice in the Newborn

Comparison of Transcutaneous or Laboratory Measurement of Bilirubin in the Newborn

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Accepted

Summary

Prospective comparison of measurement of bilirubin in jaundiced newborns by a transcutaneous device (bilirubinometer) and laboratory analysis of blood samples. We hypothesise that correlation of the two measurements depend on bilirubin level, gestational age as well as postnatal age.

Detailed description

Whenever a blood sample is drawn for measurement of bilirubin in a newborn, a transcutaneous measurement of skin yellow color will be made. Such measurements will also be included in all infants when a CRP-test (blood sample for C-reactive protein) has been ordered, as well as in connection with the routine blood sampling for metabolic screening. Only infants where parents have given written consent for their infant will be included in the study.

Conditions

Interventions

TypeNameDescription
PROCEDUREMeasurement of bilirubin in blood and skin colorBlood sampling and analysis, measurement of skin color by transcutaneous bilirubinometry

Timeline

Start date
2010-07-01
Primary completion
2013-04-01
Completion
2013-10-01
First posted
2010-07-26
Last updated
2017-03-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01169740. Inclusion in this directory is not an endorsement.